| DRUG WATCH |
|
| Year : 2015 | Volume
: 47
| Issue : 6 | Page : 682-684 |
A rare case of isoniazid-induced erythroderma
Yashika Garg1, Rajeshwari Gore1, Sourabh Jain2, Arun Kumar1
1 Department of Pharmacology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
2 Department of Dermatology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
Correspondence Address:
Dr. Yashika Garg
Department of Pharmacology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.169575
Tuberculosis is a common infectious disease in developing countries. Isoniazid is established the first-line antitubercular drug and an essential component of all antitubercular regimens. Erythroderma caused by isoniazid is an uncommon but serious adverse drug reaction. We report here a case of a 63-year-old female patient who presented with generalized redness and scaling with itching after 8 weeks of antitubercular treatment (ATT). ATT was stopped immediately, and antihistaminics were started. The patient improved over a period of 2 weeks. On sequential rechallenge, she developed similar lesions all over the body with isoniazid, hence confirming the diagnosis of isoniazid-induced erythroderma.
[FULL TEXT] [PDF]*
|
